human
adenoviru
hadv
nonenvelop
icosahedr
dna
viru
highli
preval
human
sinc
discoveri
earli
hadv
genotyp
includ
previous
character
serotyp
describ
current
seven
hadv
speci
identifi
classifi
genu
mastadenoviru
famili
hadv
infect
larg
varieti
cell
type
tissu
human
lead
broad
array
diseas
includ
acut
respiratori
infect
ari
febril
exud
acut
cystiti
rare
case
although
hadv
infect
gener
asymptomat
immunocompet
individu
acut
hadv
diseas
signific
impact
children
especi
year
age
elderli
immunosuppress
individu
militari
hadv
replic
sever
cell
type
vitro
associ
product
infect
differ
tissu
human
sever
hadv
speci
present
vari
tissu
specif
instanc
hadv
c
serotyp
commonli
associ
acut
tonsil
respiratori
diseas
wherea
serotyp
hadv
serotyp
typic
associ
gastrointestin
infect
rel
sever
highli
contagi
form
epidem
keratoconjunct
follow
hadv
replic
cycl
viral
genom
persist
fact
best
exemplifi
persist
hadv
c
primari
infect
respiratori
tract
intermitt
viral
excret
nasopharyng
secret
np
numer
studi
shown
lymphocyt
tonsil
adenoid
essenti
site
hadv
persist
name
speci
inde
semin
studi
indic
abil
hadv
persist
tonsil
adenoid
sinc
possibl
recov
hadv
tissu
week
month
establish
explant
recent
studi
use
tissu
cell
separ
sort
reveal
hadv
dna
present
lymphocyt
tonsil
addit
sever
establish
human
lymphocyt
cell
line
includ
lymphoblastoid
cell
line
deriv
bone
marrow
transplant
recipi
adenoviru
pneumonia
may
sustain
prolong
noncytopath
adenoviru
although
substanti
knowledg
obtain
regard
mechan
associ
viral
persist
human
cell
line
strategi
viral
persist
reactiv
human
lymphoid
tissu
vivo
poorli
elucid
fact
cell
type
involv
process
viral
reactiv
vivo
possibl
role
hadv
replic
may
play
develop
chronic
diseas
adenotonsillar
hypertrophi
recurr
tonsil
entir
understood
present
studi
hadv
replic
adenotonsillar
hypertrophi
conduct
help
comprehend
associ
viral
replic
tissu
shed
secret
develop
adenotonsillar
hypertrophi
recurr
tonsil
quantif
hadv
genom
detect
mrna
hadv
hexon
gene
perform
human
adenoid
tonsil
np
peripher
blood
pb
patient
tonsillar
hypertrophi
compar
obtain
sampl
control
patient
present
studi
conduct
accord
principl
express
helsinki
declar
approv
local
research
ethic
committe
patient
caregiv
sign
inform
consent
voluntarili
agre
particip
survey
studi
evalu
presenc
hadv
differ
sampl
tissu
secret
upper
respiratori
tract
children
obstruct
sleep
apnea
osa
recurr
tonsil
compar
result
control
patient
fragment
surgic
remov
adenoid
palatin
tonsil
pt
well
sampl
np
pb
obtain
patient
male
age
year
median
year
underw
adenotonsillectomi
due
osa
recurr
tonsil
small
punch
biopsi
tonsillar
tissu
np
pb
also
obtain
control
patient
male
median
year
undergo
cochlear
implant
absenc
chronic
adenotonsil
without
ari
symptom
normal
nasofibroscopi
patient
enrol
studi
undergo
treatment
otorhinolaryngolog
divis
clinic
hospit
univers
paulo
medic
school
citi
preto
brazil
may
juli
exclus
criteria
patient
control
group
compris
presenc
ari
symptom
time
surgic
procedur
use
antibiot
within
one
month
surgeri
osa
diagnos
clinic
evalu
recurr
tonsil
use
paradis
detail
descript
criteria
use
diseas
classif
method
use
clinic
sampl
process
previous
publish
research
tissu
sampl
includ
sick
healthi
individu
maintain
preserv
solut
rna
later
invitrogen
carlsbad
ca
nucleic
acid
extract
dna
rna
extract
approxim
mg
adenotonsillar
tissu
sampl
use
allprep
dna
rna
mini
kit
qiagen
hilden
germani
respect
total
nucleic
acid
extract
np
ml
pb
use
qiaamp
minelut
viru
spin
kit
qiaamp
rna
dna
blood
mini
kit
respect
qiagen
gmbh
nucleic
acid
extract
procedur
perform
accord
manufactur
instruct
hadv
detect
perform
taqman
pcr
pcr
follow
previous
publish
briefli
final
reaction
volum
contain
ng
dna
mm
forward
revers
primer
mm
probe
taqman
master
mix
appli
biosystem
foster
citi
ca
underw
follow
cycl
paramet
minut
follow
cycl
second
minut
pcr
assay
done
stepon
plu
thermocycl
appli
biosystem
qpcr
rnasep
refer
gene
conduct
simultan
tissu
secret
sampl
applic
measur
prevent
pcr
reaction
taken
includ
sampl
handl
mix
prepar
done
separ
room
addit
pcr
plate
includ
appropri
blank
quantit
pcr
qpcr
hadv
target
region
use
viral
detect
hexon
gene
quantifi
viral
genom
qpcr
assay
includ
standard
curv
produc
use
serial
decim
dilut
plasmid
target
dna
sequenc
hadv
hexon
gene
clone
detect
limit
assay
approxim
one
copi
hadv
hexon
gene
qpcr
hadv
consid
posit
threshold
reach
cycl
hadv
qpcr
assay
perform
triplic
result
normal
amplif
rnasep
gene
includ
duplic
test
batch
approach
viral
load
determin
number
copi
hadv
dna
per
gram
tissu
ml
np
blood
hexon
gene
mrna
detect
perform
revers
transcript
pcr
tissu
np
sampl
ascertain
presenc
hadv
replic
use
strategi
use
previous
publish
human
bocaviru
hbov
briefli
revers
transcript
rt
perform
mg
rna
use
pmol
oligo
dt
primer
accord
manufactur
protocol
pcr
carri
use
ng
cdna
mm
primer
mm
probe
ml
taqman
univers
pcr
master
mix
appli
biosystem
follow
condit
describ
total
rna
extract
product
treat
dnase
invitrogen
hour
pcr
ensur
amplif
neg
control
rna
extract
product
use
pcr
without
previou
rt
sampl
consid
hadv
hexon
mrna
also
simultan
neg
target
use
extract
rna
without
previou
rt
sampl
includ
cdna
rna
pretreat
dnase
test
pcr
mrna
follow
previous
describ
molecular
type
assay
base
convent
amplif
sequenc
hypervari
region
contain
hexon
gene
perform
determin
speci
hadv
present
patient
includ
studi
follow
previous
publish
briefli
first
pcr
reaction
conduct
use
final
volum
contain
ng
dna
forward
revers
primer
mm
ph
mm
mm
kcl
deoxynucleotid
triphosph
u
taq
dna
polymeras
invitrogen
cycl
condit
minut
follow
cycl
minut
minut
minut
final
extens
minut
second
pcr
nest
reaction
first
pcr
product
amplifi
use
paramet
describ
follow
forward
revers
primer
respect
amplifi
product
separ
agaros
gel
product
purifi
use
qiaquick
pcr
purif
kit
qiagen
chatsworth
ca
usa
sanger
sequenc
perform
direct
use
abi
prism
bigdy
termin
cycl
sequenc
readi
reaction
kit
ver
primer
abi
dna
sequenc
appli
biosystem
maximum
likelihood
ml
phylogenet
tree
infer
use
nucleotid
sequenc
strain
adenovirus
describ
studi
repres
member
adenovirida
famili
multipl
sequenc
align
gener
use
mafft
manual
adjust
ml
tree
construct
use
version
softwar
ultrafast
bootstrap
nucleotid
model
determin
bayesian
inform
criterion
consid
revers
dna
substitut
statist
support
individu
node
estim
use
bootstrap
valu
phylogenet
tree
visual
figtre
program
studi
associ
replic
hadv
presenc
respiratori
virus
adenotonsillar
tissu
analyz
sampl
test
presenc
follow
respiratori
virus
pcr
accord
previous
describ
human
enteroviru
human
rhinoviru
human
respiratori
syncyti
viru
human
metapneumoviru
influenza
b
human
parainfluenza
human
coronaviru
hbov
posit
neg
tissu
hadv
pcr
test
regard
presenc
hadv
antigen
immunohistochemistri
fragment
adenoid
pt
tissu
fix
hour
formaldehyd
dehydr
embed
paraffin
subsequ
section
place
microscop
slide
tissu
section
deparaffin
xylen
rehydr
decreas
concentr
ethanol
antigen
retriev
section
treat
trypsin
distil
water
calcium
chlorid
ph
minut
detect
hadv
antigen
tissu
section
wash
salin
pb
incub
hour
pb
bovin
serum
albumin
bsa
hors
serum
incub
hour
mous
monoclon
antibodi
millipor
billerica
dilut
pbsbsa
ph
triton
st
loui
mo
room
temperatur
section
incub
biotinyl
hors
antimous
igg
vector
burlingam
ca
dilut
pb
ph
minut
room
temperatur
detect
biotinyl
antibodi
carri
ultrasensit
polym
color
develop
obtain
use
novar
vector
slide
counterstain
hematoxylin
eosin
mount
permount
thermo
fisher
scientif
waltham
posit
control
cell
hadv
atcc
suspend
small
volum
human
plasma
clot
treatment
thrombin
fix
equal
treat
noninfect
cell
use
neg
control
patient
group
compar
use
fisher
exact
test
viral
load
among
patient
group
assess
use
unpair
test
comparison
three
group
conduct
analysi
varianc
bonferroni
test
assay
carri
use
graphpad
prism
softwar
version
mac
graphpad
softwar
san
diego
ca
p
valu
less
equal
adopt
signific
patient
chronic
adenotonsillar
diseas
hadv
detect
pcr
adenoid
andor
tonsil
patient
hadv
found
simultan
tissu
np
suggest
patient
could
product
hadv
infect
adenoid
andor
pt
viru
identifi
pcr
pb
enrol
patient
indic
lack
viremia
spite
hadv
detect
upper
airway
hadv
detect
significantli
p
often
adenoid
pt
tabl
frequenc
hadv
detect
tonsillar
tissu
patient
chronic
adenotonsillar
diseas
significantli
differ
observ
tissu
control
patient
tabl
detect
hadv
adenoid
pt
significantli
associ
specif
clinic
featur
includ
degre
nasal
obstruct
sleep
apnea
otiti
media
effus
ome
allergi
tabl
among
analyz
paramet
fact
worth
mention
viral
codetect
significantli
frequent
p
tissu
posit
hadv
one
tabl
median
hadv
load
determin
qpcr
adenoid
patient
chronic
adenotonsillar
diseas
copi
genomeg
mean
copiesg
control
patient
median
hadv
load
copiesg
mean
copiesg
pt
patient
chronic
adenotonsillar
diseas
median
hadv
load
copiesg
mean
copiesg
wherea
control
group
median
copiesg
mean
copiesg
regard
np
sampl
median
hadv
load
copiesml
mean
copiesml
copiesml
mean
copiesml
patient
without
chronic
adenotonsillar
diseas
respect
median
hadv
load
almost
three
time
higher
adenoid
infect
site
although
differ
signific
figur
howev
hadv
load
adenoid
uniformli
high
compar
sampl
site
patient
figur
differ
hadv
viral
load
patient
chronic
adenotonsillar
diseas
control
signific
figur
gener
hadv
load
adenoid
pt
np
significantli
differ
among
patient
without
sever
clinic
featur
analyz
present
studi
figur
note
hadv
viral
load
significantli
higher
patient
sleep
apnea
copiesg
without
condit
copiesg
p
although
lower
patient
ome
copiesg
without
diseas
copiesg
p
hadv
load
also
significantli
lower
pt
patient
ome
copiesg
without
condit
copiesg
p
suggest
higher
hadv
load
may
possibl
protect
factor
develop
ome
howev
sinc
number
patient
group
small
overlap
two
popul
includ
patient
recurr
tonsil
adenotonsillar
hypertrophi
group
kind
conclus
find
riski
hadv
load
patient
without
simultan
detect
viru
sampl
site
also
compar
well
influenc
codetect
respiratori
virus
hadv
load
analysi
suggest
appar
trend
patient
hadv
multipl
infect
site
higher
hadv
load
individu
hadv
detect
one
infect
site
although
differ
signific
analysi
varianc
appli
bonferroni
figur
therefor
hadv
load
adenotonsillar
tissu
significantli
associ
detect
viru
np
simultan
detect
respiratori
virus
figur
figur
high
frequenc
patient
signific
viral
load
adenotonsillar
tissu
copiesg
tissu
along
high
rate
hadv
detect
np
indic
enrol
patient
product
infect
thu
verifi
presenc
activ
viral
gene
express
suggest
viral
replic
adenoid
tonsil
attempt
detect
mrna
hexon
gene
tissu
hexon
gene
mrna
found
adenoid
pt
np
importantli
presenc
hadv
mrna
correl
high
viral
load
mainli
adenoid
figur
indic
latter
appear
primari
site
hadv
replic
patient
tonsillar
hypertrophi
presenc
hadv
hexon
gene
mrna
adenoid
associ
age
sex
specif
clinic
featur
analyz
present
studi
includ
presenc
sleep
apnea
ome
recurr
tonsil
intens
airway
obstruct
tabl
remark
mrna
hadv
hexon
gene
detect
one
adenoid
biopsi
obtain
control
patient
without
adenotonsillar
diseas
tabl
indic
replic
activ
hadv
tonsil
necessarili
lead
develop
chronic
adenotonsillar
diseas
demonstr
hadv
speci
replic
establish
persist
adenoid
pt
enrol
patient
amplif
sequenc
hypervari
region
hexon
gene
attempt
patient
pcr
posit
hadv
convent
visual
dna
product
agaros
gel
rang
bp
size
figur
alway
use
dna
obtain
adenoid
tissu
palatin
nasopharyng
secret
sampl
posit
base
phylogenet
analysi
figur
isol
classifi
human
mastadenoviru
c
relat
hadv
type
other
cluster
hadv
type
hadv
type
also
four
isol
group
hadv
type
human
mastadenoviru
b
one
classifi
human
mastadenoviru
e
cluster
hadv
type
interestingli
viral
replic
detect
human
mastadenoviru
adenoid
indic
speci
abl
replic
effici
tonsillar
tissu
contrast
tissu
infect
hadv
b
e
show
sign
viral
replic
indic
adenotonsillar
tissu
sustain
nonproduct
infect
hadv
b
e
local
site
hadv
replic
vivo
histolog
section
hadv
neg
tissu
test
immunohistochemistri
use
antibodi
figur
presenc
posit
control
consist
cell
viral
structur
protein
detect
epitheli
layer
adenoid
four
patient
hadv
detect
pcr
also
hadv
simultan
detect
subepitheli
layer
lymphoid
parenchyma
pt
one
patient
posit
immunohistochemistri
patient
also
posit
viral
mrna
detect
thu
conclud
hadv
c
replic
epitheli
lymphoid
cell
adenoid
pt
hadv
among
lead
caus
agent
ari
addit
caus
ari
previou
studi
group
show
hadv
one
frequent
respiratori
virus
detect
children
chronic
adenotonsillar
diseas
absenc
ari
near
detect
rate
hadv
genom
report
herein
confirm
previou
find
agre
adenoid
prefer
site
hadv
infect
compar
hadv
detect
pb
patient
tonsil
presenc
product
endotheli
cell
fibroblast
activ
lymphocyt
essenti
mechan
persist
present
studi
patient
without
symptom
ari
acut
tonsil
hadv
undetect
pb
suggest
asymptomat
viremia
frequent
asymptomat
hadv
carrier
previous
publish
group
small
cohort
hadv
detect
frequent
tonsil
tissu
codetect
respiratori
virus
present
howev
demonstr
herein
codetect
link
higher
hadv
load
copiesg
detect
mrna
hadv
hexon
gene
find
indic
presenc
hadv
tonsil
without
evid
structur
viral
protein
product
associ
simultan
increas
permiss
adenotonsillar
tissu
respiratori
virus
furthermor
observ
infer
hadv
replic
activ
reduc
presenc
coinfect
respiratori
virus
although
adenoviru
dna
frequent
found
tonsil
adenoid
intestin
tissu
vari
case
infecti
virus
rare
detect
tissu
measur
situ
hybrid
cocultur
permiss
corrobor
find
abl
detect
mrna
signal
product
infect
tonsillar
tissu
patient
suggest
major
hadv
patient
chronic
adenotonsillar
diseas
persist
nonproduct
infect
among
respiratori
diseas
virus
speci
hadv
b
hadv
c
hadv
e
frequent
describ
capabl
replic
respiratori
expect
found
speci
hadv
c
hadv
b
hadv
e
adenoid
obtain
studi
patient
interestingli
viral
mrna
detect
adenoid
patient
infect
indic
hadv
c
abl
replic
chronic
inflam
adenoid
analyz
recent
studi
point
possibl
adenotonsillar
tissu
act
site
dna
respiratori
viru
product
help
viral
spread
healthi
individu
sinc
hadv
hbov
frequent
undetect
asymptomat
individu
adenotonsillectomi
fact
publish
data
demonstr
lymphoid
cell
adenoid
pt
intestin
lamina
propria
main
site
hadv
latenc
human
epitheli
cell
tissu
essenti
viru
product
shed
np
addit
corrobor
find
hadv
antigen
detect
epitheli
layer
adenoid
patient
immunohistochemistri
studi
suggest
epitheli
cell
tonsillar
tissu
compris
site
viral
prolifer
preced
viral
dissemin
also
detect
hadv
antigen
lymphoid
parenchyma
one
patient
indic
cell
asid
epitheli
cell
sustain
hadv
replic
tonsillar
tissu
persist
infect
hadv
associ
chronic
airway
obstruct
diseas
children
studi
hadv
antigen
genom
found
bronchoalveolar
lavag
children
asthma
respect
present
studi
detect
hadv
significantli
correl
chronic
adenotonsillar
diseas
respiratori
symptom
ome
detect
diseas
phenotyp
clinic
studi
associ
detect
respiratori
virus
ome
viral
infect
caus
respiratori
syncyti
viru
influenza
viru
type
b
adenoviru
shown
increas
risk
ome
part
attribut
viral
infect
facilit
colon
nasopharynx
streptococcu
pneumonia
haemophilu
influenza
adhes
pneumonia
epitheli
cell
respiratori
contrast
develop
sleep
apnea
partial
associ
upper
airway
obstruct
due
enlarg
pt
adenoid
seen
significantli
often
obes
patient
asymptomat
viral
infect
caus
proinflammatori
cytokin
releas
viscer
adipocyt
seem
contribut
tonsillar
inflamm
develop
sleep
although
substanti
associ
hadv
sever
adenotonsillar
enlarg
found
studi
signific
correl
observ
regard
hadv
quantiti
presenc
sleep
apnea
ome
present
studi
shown
patient
without
ome
significantli
higher
viral
load
individu
condit
virus
human
cytomegaloviru
known
target
dendrit
cell
subvert
compromis
host
adapt
immun
interf
cellular
transport
major
histocompat
complex
dendrit
cell
infect
hadv
strongli
stimul
cell
may
result
increas
cellular
respons
infecti
agent
protect
host
develop
ome
addit
persist
adenovir
infect
small
hadv
load
could
function
chronic
stimulu
develop
ome
contrast
patient
sleep
apnea
exhibit
significantli
higher
hadv
load
individu
lack
condit
cellular
humor
respons
critic
control
hadv
infect
recruit
macrophag
natur
killer
cell
lead
releas
rang
proinflammatori
cytokin
stimul
cell
consequ
b
cell
prolifer
humor
antibodi
thu
keep
idea
reason
consid
high
level
hadv
may
induc
product
proinflammatori
vasoact
cytokin
increas
chanc
develop
apnea
conclus
present
studi
demonstr
high
proport
patient
chronic
adenotonsillar
diseas
persist
hadv
infect
adenoid
tonsil
howev
presenc
product
hadv
infect
associ
sever
nasal
obstruct
recurr
tonsil
viral
coinfect
presenc
higher
hadv
load
patient
apnea
parallel
protect
effect
secretori
otiti
media
indic
addit
studi
requir
provid
definit
role
hadv
chronic
adenotonsillar
diseas
